Creating compelling proposals often requires a significant amount of time and resources, but with the right proposal ...

LAWRENCEVILLE, N.J., June 17, 2025 (GLOBE NEWSWIRE) -- IMUNON, Inc. (NASDAQ: IMNN) , a clinical-stage company focused on developing non-viral DNA-mediated immunotherapies and evaluating an ...

News GlobeNewswire IMUNON Announces PlaCCine® DNA Vaccine Technology Abstract Selected for Oral Presentation at 10th International Conference on Vaccines Research & Development™ ...